Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

William Adrian Hall MD

William Adrian Hall MD

Assistant Professor

Institution: Medical College of Wisconsin
Department: Radiation Oncology
Program: Clinical

Member of the Cancer Center


Publications

  • Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer. (Tsai S, George B, Wittmann D, Ritch PS, Krepline AN, Aldakkak M, Barnes CA, Christians KK, Dua K, Griffin M, Hagen C, Hall WA, Erickson BA, Evans DB) Ann Surg 2018 Oct 11 PMID: 30312198 10/13/2018    
  • Imaging predictors of treatment outcomes in rectal cancer: An overview. (Mahadevan LS, Zhong J, Venkatesulu B, Kaur H, Bhide S, Minsky B, Chu W, Intven M, van der Heide UA, van Triest B, Krishnan S, Hall WA) Crit Rev Oncol Hematol 2018 Sep;129:153-162 PMID: 30097234 08/12/2018    
  • PET-based Treatment Response Assessment for Neoadjuvant Chemoradiation in Pancreatic Adenocarcinoma: An Exploratory Study. (Dalah E, Tai A, Oshima K, Hall WA, Erickson B, Li XA) Transl Oncol 2018 Oct;11(5):1104-1109 PMID: 30015263 PMCID: PMC6070701 07/18/2018    
  • Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for stage II and III disease. (Kolarich A, George TJ Jr, Hughes SJ, Delitto D, Allegra CJ, Hall WA, Chang GJ, Tan SA, Shaw CM, Iqbal A) Cancer 2018 Sep 01;124(17):3510-3519 PMID: 29984547 07/10/2018       2 Citations
  • Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review. (Gilbride L, Siker M, Bovi J, Gore E, Schultz C, Hall WA) Neurosurgery 2018 May 01;82(5):595-603 PMID: 29669114 04/19/2018    
  • Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes. (Hall WA, Pugh SL, Wefel JS, Armstrong TS, Gilbert MR, Brachman DG, Werner-Wasik M, Wendland MM, Brown PD, Chao ST, Roof KS, Robins HI, Mehta MP, Curran WJ Jr, Movsas B) Neurosurgery 2019 Jan 01;84(1):66-76 PMID: 29618054 04/05/2018    
  • Correlation of ADC With Pathological Treatment Response for Radiation Therapy of Pancreatic Cancer. (Dalah E, Erickson B, Oshima K, Schott D, Hall WA, Paulson E, Tai A, Knechtges P, Li XA) Transl Oncol 2018 Apr;11(2):391-398 PMID: 29455085 PMCID: PMC5852406 02/20/2018    
  • Pancreatic gross tumor volume contouring on computed tomography (CT) compared with magnetic resonance imaging (MRI): Results of an international contouring conference. (Hall WA, Heerkens HD, Paulson ES, Meijer GJ, Kotte AN, Knechtges P, Parikh PJ, Bassetti MF, Lee P, Aitken KL, Palta M, Myrehaug S, Koay EJ, Portelance L, Ben-Josef E, Erickson BA) Pract Radiat Oncol 2018 Mar - Apr;8(2):107-115 PMID: 29426692 02/11/2018       2 Citations
  • Adaptive radiation dose escalation in rectal adenocarcinoma: a review. (Van Wickle JD, Paulson ES, Landry JC, Erickson BA, Hall WA) J Gastrointest Oncol 2017 Oct;8(5):902-914 PMID: 29184696 PMCID: PMC5674246 12/01/2017    
  • Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy. (Delitto D, George TJ Jr, Loftus TJ, Qiu P, Chang GJ, Allegra CJ, Hall WA, Hughes SJ, Tan SA, Shaw CM, Iqbal A) J Natl Cancer Inst 2018 May 01;110(5):460-466 PMID: 29165692 PMCID: PMC6279292 11/23/2017    
  • Optimized -value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging. (Hurrell SL, McGarry SD, Kaczmarowski A, Iczkowski KA, Jacobsohn K, Hohenwalter MD, Hall WA, See WA, Banerjee A, Charles DK, Nevalainen MT, Mackinnon AC, LaViolette PS) J Med Imaging (Bellingham) 2018 01;5(1):011004 PMID: 29098169 PMCID: PMC5658575 11/04/2017    
  • Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference. (Hall WA, Bergom C, Thompson RF, Baschnagel AM, Vijayakumar S, Willers H, Li XA, Schultz CJ, Wilson GD, West CML, Capala J, Coleman CN, Torres-Roca JF, Weidhaas J, Feng FY) Int J Radiat Oncol Biol Phys 2018 Jun 01;101(2):274-284 PMID: 28964588 10/02/2017    
  • Should functional renal scans be obtained prior to upper abdominal IMRT for pancreatic cancer? (Blitzer GC, Hall WA, Tsai S, Aldakkak M, Hellman RS, Evans DB, Christians KK, George B, Ritch PS, Erickson BA) Pract Radiat Oncol 2017 Nov - Dec;7(6):e449-e455 PMID: 28886941 09/10/2017    
  • Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy? (Barnes CA, Krepline AN, Aldakkak M, Clarke CN, Christians KK, Khan AH, Hunt BC, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S) J Gastrointest Surg 2017 Nov;21(11):1793-1803 PMID: 28849366 08/30/2017       2 Citations
  • Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation. (Zhong J, Patel K, Switchenko J, Cassidy RJ, Hall WA, Gillespie T, Patel PR, Kooby D, Landry J) Cancer 2017 Sep 15;123(18):3486-3493 PMID: 28493288 PMCID: PMC5589506 05/12/2017       10 Citations
  • Considerations Regarding the Role of Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma in the Elderly. (Hall WA, Erickson B) J Oncol Pract 2017 03;13(3):171-172 PMID: 28282275 03/11/2017    
  • Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiation therapy of pancreatic cancer. (Heerkens HD, Hall WA, Li XA, Knechtges P, Dalah E, Paulson ES, van den Berg CA, Meijer GJ, Koay EJ, Crane CH, Aitken K, van Vulpen M, Erickson BA) Pract Radiat Oncol 2017 Mar - Apr;7(2):126-136 PMID: 28089481 01/17/2017       5 Citations
  • Biomarkers of Outcome in Patients With Localized Prostate Cancer Treated With Radiotherapy. (Hall WA, Lawton CA, Jani AB, Pollack A, Feng FY) Semin Radiat Oncol 2017 01;27(1):11-20 PMID: 27986207 12/18/2016       4 Citations
  • A Computed Tomography Imaging Feature of Pancreatic Cancer As a Predictive Biomarker for Escalated Dose Radiation Therapy. (Moningi S, Amer A, Colbert LE, Lee Y, Hall WA, Erickson BA, Varadhachary GR, Das P, Taniguchi CM, Fleming JB, Katz M, Crane CH, Koay EJ) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E171-E172 PMID: 27673966 09/28/2016    
  • Pancreatic Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Radiomic Metrics Correlate With Pathologic Molecular Markers: An Exploratory Analysis. (Hall WA, Paulson ES, Vistocky A, Tsai S, Koay EJ, Knechtges PM, Evans D, Christians K, Ritch P, George B, Oshima K, Li A, Erickson BA) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E178-E179 PMID: 27673981 09/28/2016    
  • Outcome Analysis of Treatment in Stage IIA, T3N0 Rectal Adenocarcinoma in the Veterans Health Administration (VHA). (Hall WA, Lans D, Arce-Lara C, Kelley MJ, Santana-Davila R, Marcus DM, Tsai S, Ridolfi T, Erickson BA, Gore EM) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E186 PMID: 27674006 09/28/2016    
  • Radiation for Pancreatic Adenocarcinoma: An End-of-Life Treatment? Assessing Appropriate Radiation Therapy Utilization in the National Cancer Data Base (NCDB). (Colbert LE, Dharmarajan KV, Switchenko J, Taniguchi CM, Hall WA, Gillespie TW, Kooby DA, Lipscomb J, Landry JC) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):S195 PMID: 27675761 09/28/2016    
  • NRG Oncology/RTOG 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results. (Watkins Bruner D, Pugh SL, Lee WR, Dignam JJ, Low D, Swanson GP, Shah AB, D'Souza DP, Michalski JM, Dayes IS, Seaward SA, Nguyen PL, Hall WA, Pisansky TM, Chen Y, Sandler HM, Movsas B) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):S2-S3 PMID: 27675773 09/28/2016    
  • Correlation of ADC Texture With Treatment Response for Chemoradiation Therapy of Pancreatic Cancer. (Schott D, Hall WA, Gilat Schmidt T, Dalah E, Oshima K, Paulson ES, Knechtges PM, Erickson BA, Li A) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):S70 PMID: 27675998 09/28/2016    
  • TNFRSF10C copy number variation is associated with metastatic colorectal cancer. (Tanenbaum DG, Hall WA, Colbert LE, Bastien AJ, Brat DJ, Kong J, Kim S, Dwivedi B, Kowalski J, Landry JC, Yu DS) J Gastrointest Oncol 2016 Jun;7(3):306-14 PMID: 27284460 PMCID: PMC4880759 06/11/2016    
  • The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate. (Hall WA, Nickleach DC, Master VA, Prabhu RS, Rossi PJ, Godette K, Cooper S, Jani AB ) Cancer. 2013 Sep 15;119(18):3272-9 08/13/2015    
  • Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. (Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC) Cancer. 2014 Feb 15;120(4):499-506 PMID: 24390739 08/13/2015    
  • Chromodomain Helicase Binding Protein 5 (CHD5) Is Associated With Improved Overall Survival In Patients Undergoing Adjuvant Therapy For Resected Pancreatic Adenocarcinoma. (Hall WA, Hardy CW, Colbert LE, Landry JC, Fisher SB, Sarka B, Petrova AV, Pantazides BG, Maithel SK, Kowalski J, Gandhi K, Kooby D, El-Rayes BF, Staley CA, Adsay V, Yu DS.) Oncogene. ePub Nov 25, 2013. PMID: 24276239. 08/13/2015    
  • Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base. (Mikell JL, Gillespie TW, Hall WA, Nickleach DC, Liu Y, Lipscomb J, Ramalingam SS, Rajpara RS, Force SD, Fernandez FG, Owonikoko TK, Pillai RN, Khuri FR, Curran WJ, Higgins KA) J Thorac Oncol 2015 Mar;10(3):462-71 PMID: 25384064 PMCID: PMC4336617 11/11/2014       33 Citations
  • Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia. (Mikell JL, Waller EK, Switchenko JM, Rangaraju S, Ali Z, Graiser M, Hall WA, Langston AA, Esiashvili N, Khoury HJ, Khan MK) Int J Radiat Oncol Biol Phys 2014 Jun 01;89(2):360-9 PMID: 24837891 05/20/2014       7 Citations
  • The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma. (Hall WA, Colbert LE, Nickleach D, Switchenko J, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, Kauh J, Landry JC) J Gastrointest Oncol 2014 Apr;5(2):77-85 PMID: 24772334 PMCID: PMC3999628 04/29/2014    
  • Reduced acute toxicity associated with the use of volumetric modulated arc therapy for the treatment of adenocarcinoma of the prostate. (Hall WA, Colbert L, Nickleach D, Shelton J, Marcus DM, Switchenko J, Rossi PJ, Godette K, Cooper S, Jani AB) Pract Radiat Oncol 2013 Oct-Dec;3(4):e157-64 PMID: 24674413 03/29/2014    
  • CHD7 expression predicts survival outcomes in patients with resected pancreatic cancer. (Colbert LE, Petrova AV, Fisher SB, Pantazides BG, Madden MZ, Hardy CW, Warren MD, Pan Y, Nagaraju GP, Liu EA, Saka B, Hall WA, Shelton JW, Gandhi K, Pauly R, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Curran WJ Jr, Landry JC, Maithel SK, Yu DS) Cancer Res 2014 May 15;74(10):2677-87 PMID: 24626090 PMCID: PMC4025946 03/15/2014       12 Citations
  • Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy. (Prabhu RS, Hanasoge S, Magliocca KR, Hall WA, Chen SA, Higgins KA, Saba NF, El-Deiry M, Grist W, Wadsworth JT, Chen AY, Beitler JJ) Head Neck 2015 Jun;37(6):777-82 PMID: 24596123 03/07/2014       31 Citations
  • Extent of pathologic extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated with initial surgical resection. (Prabhu RS, Hanasoge S, Magliocca KR, Moeller BJ, Milas ZL, Hall WA, El-Deiry M, Wadsworth JT, Higgins KA, Beitler JJ) Cancer 2014 May 15;120(10):1499-506 PMID: 24510454 02/11/2014       24 Citations
  • Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. (Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC) Cancer 2014 Feb 15;120(4):499-506 PMID: 24390739 PMCID: PMC4380170 01/07/2014       28 Citations
  • Accuracy of computed tomography for predicting pathologic nodal extracapsular extension in patients with head-and-neck cancer undergoing initial surgical resection. (Prabhu RS, Magliocca KR, Hanasoge S, Aiken AH, Hudgins PA, Hall WA, Chen SA, Eaton BR, Higgins KA, Saba NF, Beitler JJ) Int J Radiat Oncol Biol Phys 2014 Jan 01;88(1):122-9 PMID: 24331658 12/18/2013       26 Citations
  • Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer. (Hall WA, Petrova AV, Colbert LE, Hardy CW, Fisher SB, Saka B, Shelton JW, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Volkan Adsay N, Curran WJ, Landry JC, Maithel SK, Yu DS) Oncogene 2014 Nov 20;33(47):5450-6 PMID: 24276239 11/28/2013       6 Citations
  • The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate. (Hall WA, Nickleach DC, Master VA, Prabhu RS, Rossi PJ, Godette K, Cooper S, Jani AB) Cancer 2013 Sep 15;119(18):3272-9 PMID: 23818401 07/03/2013       18 Citations
  • Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma. (Colbert LE, Fisher SB, Hardy CW, Hall WA, Saka B, Shelton JW, Petrova AV, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Curran WJ Jr, Landry JC, Maithel SK, Yu DS) Cancer 2013 Sep 01;119(17):3148-55 PMID: 23720157 PMCID: PMC4389890 05/31/2013       36 Citations
  • The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma. (Hall WA, Colbert LE, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, Kauh J, Landry JC) Cancer 2013 Jun 15;119(12):2350-7 PMID: 23625519 PMCID: PMC3904231 04/30/2013       7 Citations
  • Clinical outcomes for a novel 6 degrees of freedom image guided localization method for frameless radiosurgery for intracranial brain metastases. (Prabhu RS, Dhabaan A, Hall WA, Ogunleye T, Crocker I, Curran WJ, Shu HK) J Neurooncol 2013 May;113(1):93-9 PMID: 23440526 02/27/2013       14 Citations
  • Tumor size on abdominal MRI versus pathologic specimen in resected pancreatic adenocarcinoma: implications for radiation treatment planning. (Hall WA, Mikell JL, Mittal P, Colbert L, Prabhu RS, Kooby DA, Nickleach D, Hanley K, Sarmiento JM, Ali AN, Landry JC) Int J Radiat Oncol Biol Phys 2013 May 01;86(1):102-7 PMID: 23290442 01/08/2013       15 Citations
  • Treatment efficiency of volumetric modulated arc therapy in comparison with intensity-modulated radiotherapy in the treatment of prostate cancer. (Hall WA, Fox TH, Jiang X, Prabhu RS, Rossi PJ, Godette K, Jani AB) J Am Coll Radiol 2013 Feb;10(2):128-34 PMID: 23245437 12/19/2012    
  • Association of clinical response and long-term outcome among patients with biopsied orbital pseudotumor receiving modern radiation therapy. (Prabhu RS, Kandula S, Liebman L, Wojno TH, Hayek B, Hall WA, Shu HK, Crocker I) Int J Radiat Oncol Biol Phys 2013 Mar 01;85(3):643-9 PMID: 22836055 07/28/2012       11 Citations
  • Clinical outcomes of radiotherapy as initial local therapy for Graves' ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery. (Prabhu RS, Liebman L, Wojno T, Hayek B, Hall WA, Crocker I) Radiat Oncol 2012 Jun 19;7:95 PMID: 22713684 PMCID: PMC3485155 06/21/2012       14 Citations
  • Comparing central nervous system (CNS) and extra-CNS hemangiopericytomas in the Surveillance, Epidemiology, and End Results program: analysis of 655 patients and review of current literature. (Hall WA, Ali AN, Gullett N, Crocker I, Landry JC, Shu HK, Prabhu R, Curran W) Cancer 2012 Nov 01;118(21):5331-8 PMID: 22517327 04/21/2012       6 Citations
  • Stereotactic body radiosurgery for spinal metastatic disease: an evidence-based review. (Hall WA, Stapleford LJ, Hadjipanayis CG, Curran WJ, Crocker I, Shu HK) Int J Surg Oncol 2011;2011:979214 PMID: 22312536 PMCID: PMC3263656 02/09/2012    
  • Last update: 01/09/2019
    jenkins-FCD Prod-300 626508253d14e4184314fb9f66322a03a5906796